Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Vince K Grolmusz"'
Autor:
Elena Farmaki, Aritro Nath, Rena Emond, Kimya L Karimi, Vince K Grolmusz, Patrick A Cosgrove, Andrea H Bild
Publikováno v:
eLife, Vol 12 (2023)
The mTOR inhibitor, everolimus, is an important clinical management component of metastatic ER+ breast cancer (BC). However, most patients develop resistance and progress on therapy, highlighting the need to discover strategies that increase mTOR inh
Externí odkaz:
https://doaj.org/article/c96b28ace81548d2be96b829718494be
Autor:
Elena Farmaki, Aritro Nath, Rena Emond, Kimya L Karimi, Vince K Grolmusz, Patrick A Cosgrove, Andrea H Bild
SummaryThe mTOR inhibitor, everolimus, is an important clinical management component of metastatic ER+ breast cancer. However, most patients develop resistance and progress on therapy, highlighting the need to discover strategies that increase mTOR i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3e42c8c902278419a565d8e83de4ba5
https://doi.org/10.1101/2022.12.27.522019
https://doi.org/10.1101/2022.12.27.522019
Autor:
Eleni Farmaki, Rena Emond, Aritro Nath, Vince K. Grolmusz, Patrick A. Cosgrove, Andrea H. Bild
Publikováno v:
Cancer Research. 83:388-388
The mTOR inhibitor everolimus has become an important component for clinical management of metastatic ER+ breast cancer. Despite the improved patient outcomes, progression and resistance will still develop. Therefore, it is important to research stra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d61a051fa3330d4cdb2e77a7afcf54fc
https://doi.org/10.1158/1538-7445.am2023-388
https://doi.org/10.1158/1538-7445.am2023-388
Autor:
Farmaki, Elena, Nath, Aritro, Emond, Rena, Karimi, Kimya L., Grolmusz, Vince K., Cosgrove, Patrick A., Bild, Andrea H.
Publikováno v:
eLife; 9/29/2023, p1-21, 21p
Autor:
Jinfeng Chen, Rena Emond, Jason I. Griffiths, Andrea Bild, Frederick R. Adler, Vince Kornél Grolmusz
Publikováno v:
Cancer Research. 81:3133-3133
Competition between different lineages of cells within a tumor has been included in thinking about cancer evolution and progression, but positive interactions like cooperation have received far less study. We have developed isogenic estrogen positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6770e8a41f558055252e7f16386564b8
https://doi.org/10.1158/1538-7445.am2021-3133
https://doi.org/10.1158/1538-7445.am2021-3133